Bifidobacterium lactis Bb-02 and Reduced Eczema Incidence

• Bifidobacterium animalis subsp. lactis BLa80 for preventing allergic, respiratory, and gastrointestinal diseases in young children in China: a randomized double-blind placebo-controlled trial.

  • 2026-02-15
  • RCT · n = 180
  • Clinical and experimental pediatrics 69(2)
  • • Ke Chen
    • Xi Zhang
    • Kaihong Zeng
    • Jiayi Zhong
    • Shanshan Jin
    • Yang Nie
    • Ping Yang
    • Nianyang He
    • Haixia Chen
    • Yanmei Cao
    • Yunrong Fu
    • Ziji Fang
    • Wei Jiang
    • Changqi Lium

  • PubMed: 41167178
  • DOI: 10.3345/cep.2025.01256

  8 Insights on

  • Reduced Eczema Incidence

  • High evidence

  The morbidity rate of eczema during the 6-month period was significantly lower in the IG versus CG (intention-to-treat analysis: 26.1% [47 of 180] vs. 66.7% [120 of 180], P<0.01; per-protocol analysis: 30.1% [47 of 156] vs. 73.2% [120 of 164], P<0.01).

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes